Anticonvulsive pharmaceutical compositions

US9308260B2 · kind B2 · utility

Assignee

• INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) · FR

Inventors

• Serge Picaud · Avon, FR
• Jose-Alain Sahel · Paris, FR
• Jammoul Firas · Bagneux, FR
• Caroline Coriat · Paris, FR
• Manuel Simonutti · Paris, FR

Key dates

• Filing date: Jul 4, 2008
• Grant date: Apr 12, 2016
• Expiry date: Dec 20, 2030

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The use of substance selected from taurine, a taurine precursor, a taurine metabolite, a taurine derivative, a taurine analog and a substance required for the taurine biosynthesis, for preventing or inhibiting the undesirable side-effects caused to a human or an animal organism by an active ingredient that induces a high level of extracellular GABA or increases GABA receptor activation, and a pharmaceutical composition including the substance and the active ingredient.